"A Food and Drug Administration advisory panel voted on Thursday to broaden access to at least four peptides, amid a surge of interest in the unapproved therapies."https://www.cbsnews.com/news/fda-peptides-review-regulations-unapproved-therapies/?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4c92f5d78644b3ac5d5b4Ralph Ciardella
No comments:
Post a Comment